Ex-SAC Trader May Dig Own Grave At Trial, Attys Say

Law360, New York (June 6, 2013, 9:10 PM EDT) -- With a trial date now set in the insider trading case against Mathew Martoma, defense attorneys and jury experts say the former SAC Capital Advisors LP portfolio manager may be wise to avoid taking the stand and compromising his already-slim chances at victory.

A New York federal judge on Wednesday scheduled Martoma's trial to start Nov. 4. Prosecutors claim he earned an SAC unit $276 million by trading on tips about problems in an Alzheimer's drug being developed by Wyeth Ltd. and Elan Corp. PLC —...
To view the full article, register now.